Document is current
Any future updates will be listed below
-
Authors
Migliozzi, Simona
Oh, Young Taek
Hasanain, Mohammad
Garofano, Luciano
D’Angelo, Fulvio
Najac, Ryan D.
Picca, Alberto
Bielle, Franck
Di Stefano, Anna Luisa https://orcid.org/0000-0003-1746-0647
Lerond, Julie
Sarkaria, Jann N. https://orcid.org/0000-0001-7489-4885
Ceccarelli, Michele https://orcid.org/0000-0002-4702-6617
Sanson, Marc
Lasorella, Anna
Iavarone, Antonio https://orcid.org/0000-0002-0683-4634
- License Information
-
More Information
Article History
Received: 10 March 2022
Accepted: 21 December 2022
First Online: 2 February 2023
Competing interests
: A.L. and A.I. are inventors of a biomarker technology that has been licensed to QIAGEN. A.I. received sponsored research funding from AstraZeneca and Taiho Pharmaceutical and has served as a paid consultant/advisor to AIMEDBIO. A.L. received sponsored research funding from Celgene. A.L. and A.I. are inventors of a patent application based on this work. All other authors declare no competing interests.
